Biotech · Private company
Jina Pharmaceuticals Inc.
Track this companyFree. Adds Jina Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- EndoxifenPhase 3 · Bipolar I DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Endoxifen enteric-coated tablet (8 mg)Phase 3 · Bipolar 1 DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Nanosomal Docetaxel Lipid Suspension (100 mg/m2)Phase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Nanosomal Docetaxel Lipid Suspension (75 mg/m2)Phase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Taxotere® (100 mg/m2)Phase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of Endoxifen in Bipolar I Disorder PatientsPHASE3 · UNKNOWN · started Mar 19, 2024ClinicalTrials.gov NCT06608641 · fetched Nov 12, 2026
- Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder PatientsPHASE3 · COMPLETED · started Aug 3, 2020ClinicalTrials.gov NCT04315792 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer PatientsPHASE3 · RECRUITING · started Jul 10, 2018ClinicalTrials.gov NCT03671044 · fetched Nov 12, 2026